Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Thomas, Pagliardini"'
Autor:
Sumin Jo, Shipra Das, Alan Williams, Anne-Sophie Chretien, Thomas Pagliardini, Aude Le Roy, Jorge Postigo Fernandez, Diane Le Clerre, Billal Jahangiri, Isabelle Chion-Sotinel, Sandra Rozlan, Emilie Dessez, Agnes Gouble, Mathilde Dusséaux, Roman Galetto, Aymeric Duclert, Emanuela Marcenaro, Raynier Devillier, Daniel Olive, Philippe Duchateau, Laurent Poirot, Julien Valton
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
Host versus graft reaction is a major impediment to CAR-T cell immune therapy in allogeneic settings. Authors show here that CAR-T cells, engineered to be deficient in MHC I expression but to express the NK inhibitor HLA-E, are resistant to destructi
Externí odkaz:
https://doaj.org/article/a2496c352a3244febe307778e8da45cb
Autor:
Francois Dachy, Sabine Fürst, Boris Calmels, Thomas Pagliardini, Samia Harbi, Benjamin Bouchacourt, Anne Calleja, Claude Lemarie, Aude Collignon, Guillaume Morel, Faezeh Legrand, Elena Bekrieva, angela granata, Pierre-Jean Weiller, Christian CHABANNON, Jean-Marc Schiano de Colella, Norbert Vey, Didier Blaise, Raynier Devillier
After T-cell replete haploidentical stem cell transplantation, GVHD prophylaxis with post-transplant cyclophosphamide (PT-Cy) is now evaluated in unrelated donor (UD) transplants, where antithymocyte globulin (ATG) remains standard. We report the out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fae0151c5f524431e15a714c6ef8b31
https://doi.org/10.21203/rs.3.rs-2025008/v1
https://doi.org/10.21203/rs.3.rs-2025008/v1
Autor:
Claude Lemarié, Bechara Mfarrej, Sabine Furst, Didier Blaise, Sylvie Bayona, Benjamin Bouchacourt, Boris Calmels, Raynier Devillier, Catherine Faucher, Angela Granata, Samia Harbi, Faezeh Legrand, Thomas Pagliardini, Christophe Picard, Sandrine Sow, Sophie Simon, Cécile Teste, Fluzin Sylvain, Christian Chabannon
Publikováno v:
Blood. 140:12811-12812
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8caeaf9e30636b367e2dec9d55f47817
https://doi.org/10.1182/blood-2022-162290
https://doi.org/10.1182/blood-2022-162290
Autor:
Aude Collignon, Benjamin Bouchacourt, Patrick Sfumato, Gabriel Brisou, Jean Marc Schiano de Collela, Luca Inchiappa, Boris Calmels, Claude Lemarié, Tibaulth Reichert, Samia Harbi, Raynier Devillier, Anne Calleja, Thomas Pagliardini, Guillaume Morel, Angela Granata, Norbert Vey, Reda Bouabdallah, Didier Blaise, Christian Chabannon, Robin Noel, Catalina Montes De Oca
Publikováno v:
Blood. 140:7712-7713
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d64775120444bfcbc7a67dd124e6228a
https://doi.org/10.1182/blood-2022-158171
https://doi.org/10.1182/blood-2022-158171
Autor:
Samia Harbi, Christian Chabannon, Luca Castagna, Carmelo Carlo-Stella, A Granata, Jean Marc Schiano, Valerio Maisano, Thomas Pagliardini, Raynier Devillier, Aude Collignon, Armando Santoro, Didier Blaise, Chiara De Philippis, Sabine Furst, Jacopo Mariotti, Catalina Montes de Oca, Faezeah Legrand, Stefania Bramanti
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:2299-2305
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a valid option in patients with refractory lymphomas. HLA haploidentical stem cell transplantation (haplo-SCT) expanded the accessibility to allogeneic hematopoietic cell transplantatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce47f24b2cb7833a17637dd8af163a5e
https://doi.org/10.1016/j.bbmt.2020.08.014
https://doi.org/10.1016/j.bbmt.2020.08.014
Autor:
Thomas Pagliardini, Raynier Devillier, Nohra Ghaoui, Remy Dulery, Radwan Massoud, Farouk Al Chami, Florent Malard, Didier Blaise, Nour Moukalled, Jean El-Cheikh, Razan Mohty, Fabrizio Marino, Mohamad Mohty, Luca Castagna, Ali Bazarbachi, Abdul Hamid Bazarbachi
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia, 2020, 20 (9), pp.617-623. ⟨10.1016/j.clml.2020.04.003⟩
Clinical Lymphoma, Myeloma & Leukemia, 2020, 20 (9), pp.617-623. ⟨10.1016/j.clml.2020.04.003⟩
Background Graft-versus-host disease (GVHD) is a major cause of mortality after allogeneic stem-cell transplantation. Posttransplantation cyclophosphamide (PT/CY) has become standard prophylaxis of GVHD in T-replete haploidentical transplantation. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34703a584d1d166a50591a5c69dff379
https://doi.org/10.1016/j.clml.2020.04.003
https://doi.org/10.1016/j.clml.2020.04.003
Autor:
Samia Harbi, Jacopo Mariotti, Didier Blaise, Raynier Devillier, Pierre-Jean Weiller, Barbara Sarina, Chiara De Philippis, Stefania Bramanti, Armando Santoro, Luca Castagna, Remy Dulery, Laura Giordano, Sabine Furst, Reda Bouabdallah, Thomas Pagliardini, Christian Chabannon, Claude Lemarie, Faezeh Legrand-Izadifar, Mohamad Mohty, Catalina Montes de Oca, Boris Calmels, Angela Granata, Valerio Maisano
Publikováno v:
Blood Advances. 4:1242-1249
We report on 59 Hodgkin lymphoma patients undergoing haploidentical stem cell transplantation (SCT; haplo-SCT) with posttransplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis, comparing outcomes based on pretransplant expo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5671cedb4cb5b5609a3cadbd174026
https://doi.org/10.1182/bloodadvances.2019001336
https://doi.org/10.1182/bloodadvances.2019001336
Autor:
M. Fays, Bechara Mfarrej, Thomas Pagliardini, Boris Calmels, Didier Blaise, C. Malenfant, P. Lignee, A Granata, Christian Chabannon, C. Lemarie
Publikováno v:
Bone Marrow Transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42262141171e28cf98ed9c3d56705c7
http://europepmc.org/articles/PMC8040015
http://europepmc.org/articles/PMC8040015
Autor:
Sumin Jo, Shipra Das, Alan Williams, Anne-Sophie Chretien, Thomas Pagliardini, Aude Le Roy, Jorge Postigo Fernandez, Diane Le Clerre, Billal Jahangiri, Isabelle Chion-Sotinel, Agnes Gouble, Mathilde Dusséaux, Roman Galetto, Aymeric Duclert, Emanuela Marcenaro, Raynier Devillier, Daniel Olive, Philippe Duchateau, Laurent Poirot, Julien Valton
Universal CAR T-cell therapies are poised to revolutionize cancer treatment and to improve patient outcomes. However, realizing these advantages in an allogeneic setting requires universal CAR T-cells that can kill target tumor cells, avoid depletion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e1a7f69ca5d2f8c57c4049bbf8a6663
https://doi.org/10.1101/2021.12.06.471451
https://doi.org/10.1101/2021.12.06.471451
Autor:
Matteo G. Della Porta, Raynier Devillier, Angela Granata, Claude Lemarie, Boris Calmels, Samia Harbi, Lucas Castagna, Thomas Pagliardini, Colombe Saillard, Sabine Furst, Pierre-Jean Weiller, Catherine Faucher, Djamel Mokart, Faezeh Legrand, Christian Chabannon, Stefania Bramanti, Didier Blaise, Wang Lining, Norbert Vey, Valerio Maisano, Aude Charbonnier, Jerome Rey
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1803-1809
Haploidentical stem cell transplantation (haplo-SCT) with post-transplant cyclophosphamide (PT-Cy) is an alternative treatment for acute myeloid leukemia (AML) patients who lack HLA-matched donors. Relapse after haplo-SCT remains a major concern, esp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab91ad6a558c66402e33b72bc707047
https://doi.org/10.1016/j.bbmt.2019.05.014
https://doi.org/10.1016/j.bbmt.2019.05.014